In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS 

No. 15-1469V 

(Not to be Published) 

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

 * 

SUSAN BOYER, * 

 * 

 Petitioner, * Filed: October 12, 2016 

 * 

 v. * Decision; Attorney’s Fees and Costs. 

 * 

 * 

SECRETARY OF HEALTH AND * 

HUMAN SERVICES, * 

 * 

 Respondent. * 

 * 

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

Paul R. Brazil, Muller Brazil, LLP, Dresher, PA, for Petitioner. 

Ryan D. Pyles, U.S. Dep’t of Justice, Washington, DC, for Respondent. 

ATTORNEY’S FEES AND COSTS DECISION1

On December 4, 2015, Susan Boyer filed a petition seeking compensation under the 

National Vaccine Injury Compensation Program (“Vaccine Program”), alleging, among other 

things, that the influenza (“flu”) vaccine she received on October 26, 2014, caused her to develop 

transverse myelitis (“TM”) and/or acute inflammatory demyelinating polyradiculopathy 

(“AIDP”).2

 ECF No. 1. Thereafter, on August 10, 2016, the parties agreed to settle this case and I 

entered judgment accordingly. ECF No. 16. 

 

1

 Because this decision contains a reasoned explanation for my actions in this case, I will post it on the United States 

Court of Federal Claims website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). As 

provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the published decision’s inclusion of 

certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within 

which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or 

financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure 

of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole 

decision will be available to the public. Id. 

2

 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 

100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). 

Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). 
2 

Petitioner has now filed a motion for final attorney’s fees and costs, dated September 28, 

2016. ECF No. 21. Petitioner requests reimbursement of attorney’s fees and costs in the amount 

of $15,862.56. Id. Respondent has formally represented that she does not object to the sum 

requested. ECF No. 22. In addition, and in compliance with General Order No. 9, Petitioner 

represents that she has not incurred any out-of-pocket, litigation-related expenses in conjunction 

with this proceeding. ECF No. 21. 

I approve the requested amount for attorney’s fees and costs as reasonable. Accordingly, 

an award of $15,862.56 should be made in the form of a check payable jointly to Petitioner and 

Petitioner’s counsel, Paul R. Brazil, Esq. Payment of this amount represents all attorney’s fees and 

costs available under 42 U.S.C. § 300aa-15(e). In the absence of a motion for review filed pursuant 

to RCFC Appendix B, the clerk of the Court SHALL ENTER JUDGMENT in accordance with 

the terms of Petitioner’s motion.3

IT IS SO ORDERED. 

 /s/ Brian H. Corcoran

 Brian H. Corcoran 

 Special Master 

 

3

 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) 

a notice renouncing their right to seek review.